The Australasian Professional Society on Alcohol and other Drugs

The Matilda Centre for Research in Mental Health and Substance Use at the University of Sydney has been funded by the Australian Government Department of Health to update and revise the ‘Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings’ (second edition).
 
Originally published in 2009, with the second edition released in 2016, this hugely popular resource aimed to provide alcohol and other drug (AOD) workers with evidence-based information on the management of comorbid mental health conditions in AOD settings. Since publication of the second edition in July 2016, 15,000 hard and electronic copies have been distributed to clinicians and treatment services across Australia.
 
Subsequent funding from the Australian Government Department of Health enabled the development of an accompanying online training program and interactive online copy of the second edition. Since the website and online training program were launched in November 2017, close to 3,500 people have begun using the program and more than 650 people have completed the full training program. The website has attracted a monthly average of approximately 3,000 visitors (>5,650 per month in 2020).
 
The revision of the second edition will bring the Guidelines up to date with the most current evidence. The project is being undertaken by Dr Christina Marel, Prof Katherine Mills, Dr Alana Fisher, Ms Erin Madden, Prof Maree Teesson, Dr Mark Deady, Prof Frances Kay-Lambkin, Prof Amanda Baker, Prof Andrew Baillie, and Prof Kevin Gournay.
 
The revision team would be delighted if members of the alcohol and other drugs sector would be interested in participating in the revision through one (or more) of the following:

  1. Attending one of online two discussion forums;
  2. Completing a short online survey;
  3. Emailing feedback about the Guidelines directly to our team.

 
Online discussion forums
The revision team are holding two online discuss forums open to anyone, and hope that that these forums will be attended by a variety of interested stakeholders including alcohol and other drug workers, clinicians, healthcare workers, consumers and people with lived experience of mental health and substance use, family members, carers as well as academic experts. Additional discussion forums may be made available depending on demand.
 
The discussion forums will be held online on
Discussion Forum 1: Tuesday 8 September 2020, from 1 to 4pm AEST,and
Discussion Forum 2: Thursday 10 September 2020, from 9am to 12pm AEST.
 
During the forums, discussion will include the content of the Guidelines with a particular focus on how the existing resource can be improved. A copy of the current edition of the Guidelines is available for download on the Comorbidity Guidelines website:  https://comorbidityguidelines.org.au/pdf/comorbidity-guideline.pdf
 
If you are interested in participating as a discussion forum member in either forum, please register below.
 
Register for Discussion Forum 1: Tuesday 8 September 2020, from 1 to 4pm AEST
https://bit.ly/cgl-discussion-forum-1
 
Register for Discussion Forum 2: Thursday 10 September 2020, from 9am to 12pm AEST
https://bit.ly/cgl-discussion-forum-2  
 
Online survey
The online survey will take around 5 minutes to complete, and will focus on the current (2nd edition) Guidelines, and areas for improvement.

The survey will remain open until 5pm (AEST) 30th September 2020.
 
Click here to complete the online survey: https://bit.ly/cgl-second-ed-feedback
 
Send feedback directly to us
 
We also welcome any other form of feedback that can be sent directly to our team.
 
Please email This email address is being protected from spambots. You need JavaScript enabled to view it. before 5pm (AEST) 30th September 2020